Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.

Ogwang S, Asiimwe BB, Traore H, Mumbowa F, Okwera A, Eisenach KD, Kayes S, Jones-López EC, McNerney R, Worodria W, Ayakaka I, Mugerwa RD, Smith PG, Ellner J, Joloba ML.

BMC Infect Dis. 2009 Aug 26;9:139. doi: 10.1186/1471-2334-9-139.

2.

Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda.

Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K, Kayes S, Jones-Lopez EC, Smith PG, Ellner JJ, Mugerwa RD, Eisenach KD, McNerney R.

Ann Clin Microbiol Antimicrob. 2007 Jan 9;6:1.

3.

Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin.

McNerney R, Kiepiela P, Bishop KS, Nye PM, Stoker NG.

Int J Tuberc Lung Dis. 2000 Jan;4(1):69-75.

PMID:
10654647
4.

Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.

Albert H, Trollip AP, Seaman T, Abrahams C, Mole RJ, Jordaan A, Victor T, Hoosain E.

S Afr Med J. 2007 Sep;97(9):858-63.

5.

Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay.

Butt T, Ahmad RN, Afzal RK, Mahmood A, Anwar M.

J Pak Med Assoc. 2004 Jul;54(7):379-82.

6.

Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis.

Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL.

J Infect. 2005 Oct;51(3):175-87. Epub 2005 Jul 5.

PMID:
16002146
7.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

8.

Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis.

Watterson SA, Wilson SM, Yates MD, Drobniewski FA.

J Clin Microbiol. 1998 Jul;36(7):1969-73.

9.

Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.

Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, Carrilho L, Diogo J, Fonseca A, Lito L, Lopes J, Pacheco T, Pessanha M, Quirim J, Sancho L, Salfinger M, Amaral L.

J Clin Microbiol. 2005 Sep;43(9):4880-4.

10.

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.

PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26.

11.

[Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA)].

Higuchi T, Fushiwaki T, Tanaka N, Miyake S, Ogura T, Yoshida H, Takashima T, Nakagawa M, Maekura R, Hiraga T, Suetake T.

Kekkaku. 2004 Sep;79(9):525-30. Japanese.

PMID:
15552939
12.

Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).

Cirillo DM, Piana F, Frisicale L, Quaranta M, Riccabone A, Penati V, Vaccarino P, Marchiaro G.

New Microbiol. 2004 Jul;27(3):221-7.

PMID:
15460524
13.

Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.

Skenders GK, Holtz TH, Riekstina V, Leimane V.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1546-52, i. doi: 10.5588/ijtld.11.0067.

PMID:
22008771
14.
15.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review.

16.

Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.

Abanda NN, Djieugoué JY, Lim E, Pefura-Yone EW, Mbacham WF, Vernet G, Penlap VM, Eyangoh SI, Taylor DW, Leke RGF.

BMC Infect Dis. 2017 May 31;17(1):379. doi: 10.1186/s12879-017-2489-3.

17.

Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda.

Bwanga F, Haile M, Joloba ML, Ochom E, Hoffner S.

PLoS One. 2011 May 9;6(5):e19565. doi: 10.1371/journal.pone.0019565.

19.

Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test.

Albert H, Trollip AP, Mole RJ, Hatch SJ, Blumberg L.

Int J Tuberc Lung Dis. 2002 Jun;6(6):523-8.

PMID:
12068986
20.

Direct and early detection of Mycobacterium tuberculosis complex and rifampicin resistance from sputum smears.

Bhutia R, Narain K, Devi KR, Singh TS, Mahanta J.

Int J Tuberc Lung Dis. 2013 Feb;17(2):258-61. doi: 10.5588/ijtld.12.0452.

PMID:
23317964

Supplemental Content

Support Center